We have completed maintenance on DiscoverMagazine.com and action may be required on your account. Learn More

Step Towards an AIDS Vaccine? Monkey Muscles Produce HIV-Fighting Proteins

By Eliza Strickland
May 19, 2009 1:38 AMNov 5, 2019 9:00 PM


Sign up for our email newsletter for the latest science news

All's fair in the fight against the AIDS virus--including medical sneak attacks. Researchers have devised a novel strategy to attack HIV by completely bypassing the immune system and instead tricking the muscles into producing virus-fighting proteins.

The quest for an HIV vaccine has been given a bad prognosis recently, due to increasing agreement that the human immune system isn't clever enough to outsmart the ever-changing surface of the virus [Technology Review].

But using the new technique, researchers were able to protect monkeys from infection by the simian immunodeficiency virus (SIV), the animal virus most closely related to HIV. While lead researcher Philip Johnson cautions that there's no guarantee that the vaccination process will work in humans, he's eagerly looking forward to human trials in a few years.

Most efforts at blocking AIDS have sought to stimulate the body's immune system to produce antibodies that fight the disease. This model has worked for diseases such as measles and smallpox. It hasn't done as well with HIV/AIDS; test vaccines have failed to produce a protective reaction. So Johnson decided to try something different. "We used a leapfrog strategy, bypassing the natural immune system response that was the target of all previous HIV and SIV vaccine candidates," Johnson said [AP].

Johnson explains that researchers have known for some years that there are proteins that can latch onto the HIV virus and prevent it from infecting cells.

"Mother Nature has allowed us a few breaks, in that we know that in a very few cases, people who have been infected for a very long time have been able to naturally develop antibodies that neutralize a lot of the circulating virus," he said. "So, we thought perhaps we could take the genes that represent these antibodies 'off the shelf,' so to speak" [Forbes]

. The researchers engineered a piece of DNA that triggers the creation of artificial antibodies called immunoadhesins, and used a harmless virus to deliver the DNA to the muscles of nine macaque monkeys. Once the monkeys' muscles began cranking out the SIV-fighting proteins and releasing them into the bloodstream, the monkeys were injected with SIV. In the study, published in Nature Medicine, researchers found that none

of the immunized monkeys developed AIDS and only three showed any indication of SIV infection. Even a year later they had high concentrations of the protective antibodies in the blood [AP].

Six other monkeys were used as control subjects and were not given the vaccine before being injected with SIV; of those six, all became infected and four died during the experiment. Johnson says that clinical trials could begin in humans in two years' time, and adds that while he's wary of over-hyping the results,

"scientifically, we believe we are on the right track" [Forbes].

Related Content: 80beats: Scientists Film HIV Jumping From Cell to Cell for the First Time 80beats: Could an Ingredient in Ice Cream Prevent HIV Transmission? 80beats: Scientists Design Assassin Immune Cells to Kill HIV-Infected Cells 80beats: HIV Vaccine Trial Cancelled in a Setback for AIDS ResearchImage: iStockphoto

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!


Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Our List

Sign up for our weekly science updates.

To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 Kalmbach Media Co.